Effects of inhibitors of Δ24(25)-sterol methyl transferase on the ultrastructure of epimastigotes of Trypanosoma cruzi

Microscopy and Microanalysis

Volumn 11, Issue 6, 2005, Pages 506-515

  Braga, Marina V ^a,b   Magaraci, Filippo ^c   Lorente, Silvia Orenes ^c   Gilbert, Ian ^c   De Souza, Wanderley ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Chemotherapy; Ergosterol; Methyl transferase; Sterol biosynthesis inhibitors; Trypanosomatid; Ultrastructure

Indexed keywords

TRYPANOSOMA; TRYPANOSOMA CRUZI; TRYPANOSOMATIDAE;

ANTITRYPANOSOMAL AGENT; DELTA 24 STEROL METHYLTRANSFERASE; DELTA 24-STEROL METHYLTRANSFERASE; ENZYME INHIBITOR; METHYLTRANSFERASE; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; AUTOPHAGY; CELL MEMBRANE; CELL VACUOLE; DRUG ANTAGONISM; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; TRYPANOSOMA CRUZI; ULTRASTRUCTURE;

ANIMALS; AUTOPHAGY; CELL MEMBRANE; ENZYME INHIBITORS; METHYLTRANSFERASES; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI; VACUOLES;

EID: 28744437316     PISSN: 14319276     EISSN: 14358115     Source Type: Journal    
DOI: 10.1017/S143192760505035X     Document Type: Article

References (49)

1. ATTIAS, M. & DE SOUZA, W. (1985). Fine structure and cytochemistry of Phytomonas davidi. J Submicrosc Cytol 17, 205-212.
2. BRAGA, M.V., URBINA, J.A. & DE SOUZA, W. (2004). Effects of squalene synthase inhibitors on the growth and ultrastructure of Trypanosoma cruzi. Int J Antimicrob Ag 24, 72-78.
3. BRENER, Z., CANÇADO, J.R., GALVÃO, L.M., DA LUZ, Z.M.P., FILARDI, L.S., PEREIRA, M.E.S., SANTOS, L.M.T. & CANÇADO, C.B. (1993). An experimental and clinical assay with ketoconazole in the treatment of Chagas disease. Mem Inst Oswaldo Cruz 88, 149-153.
4. CARVALHO, T.U. & DE SOUZA, W. (1987). Effect of phorbol-12-myristate- 13-acetate (PMA) on the fine structure of Trypanosoma cruzi and its interaction with activated and resident macrophages. Parasitol Res 74, 11-17.
5. CONTRERAS, L.M., VIVAS, J. & URBINA, J.A. (1997). Altered lipid composition and enzyme activities of plasma membranes from Trypanosoma (Schizotrypanum) cruzi epimastigotes grown in the presence of sterol biosynthesis inhibitors. Biochem Pharmacol 53, 697-704.
6. DE SOUZA, W. (2002). Basic cell biology of Trypanosoma cruzi. Curr Pharm Des 8, 269-285.
7. DE SOUZA, W., CARVALHO, T.U. & BENCHIMOL, M. (1978a). Trypanosoma cruzi: Ultrastructural, cytochemical and freeze-fracture studies of protein uptake. Exp Parasitol 45, 101-115.
8. DE SOUZA, W., MARTINEZ-PALOMO, A. & GONZALES-ROBLES, A. (1978b). The cell surface of Trypanosoma cruzi. Cytochemistry and freeze-fracture. J Cell Sci 33, 285-299.
9. DOCAMPO, R., MORENO, S.N.J., TURRENS, J.F., KATZIN, A.M., GONZALES-CAPPA, S.M. & STOPPANI, A.O.M. (1981). Biochemical and ultrastructural alterations produced by miconazole and econazole in Trypanosoma cruzi. Mol Biochem Parasitol 3, 169-180.
10. FIGUEIREDO, R.C. & SOARES, M.J. (2000). Low temperature blocks fluid-phase pinocytosis and receptor-mediated endocytosis in Trypanosoma cruzi epimastigotes. Parasitol Res 86, 413-418.
11. GOAD, L.J., BERENS, R.L., MARR, J.J., BEACH, D.H. & HOLZ, G.G., JR. (1989). The activity of ketoconazole and other azoles against Trypanosoma cruzi: Biochemistry and chemotherapeutic action in vitro. Mol Biochem Parasitol 32, 179-190.
12. KIRCHHOFF, L.V. (1993). American Trypanosomiasis (Chagas' disease) - A tropical disease now in the United States. New Engl J Med 329, 639-644.
13. LARRALDE, G., VIVAS, J. & URBINA, J.A. (1988). Concentration and time dependence of the effects of ketoconazole on growth and sterol biosynthesis in Trypanosoma (Schizotrypanum) cruzi epimastigotes. Acta Cient Venez 39, 140-146.
14. LAZARDI, K., URBINA, J.A. & DE SOUZA, W. (1990). Ultrastructural alterations induced by two ergosterol biosynthesis inhibitors, ketoconazole and terbinafine, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi. Antimicrob Agents Chemother 34, 2097-2105.
15. LAZARDI, K., URBINA, J.A. & DE SOUZA, W. (1991). Ultrastructutal alterations induced by ICI 195,739, a bis-triazole with strong antiproliferative action against Trypanosoma (Schizotrypanum) cruzi. Antimicrob Agents Chemother 35, 736-740.
16. LIENDO, A., LAZARDI, K. & URBINA, J.A. (1998). Antiproliferative effects of D0870 on Trypanosoma (Schizotrypanum) cruzi. Antimicrob Agents Chemother 41, 197-205.
17. LINDER, J.C. & STAEHELIN, L.A. (1979). A novel model for fluid secretion by the trypanosomatid contractile vacuole apparatus. J Cell Biol 83, 371-382.
18. MAGARACI, F., JIMENEZ, C.J., RODRIGUES, C., RODRIGUES, J.C.F., BRAGA, M.V., DE SOUZA, W., URBINA, J., YARDLEY, V., DE LUCA-FRADLEY, K., CROFT, S.L., RUIZ-PEREZ, L.M., GONZALEZ-PACANOWSKA, D. & GILBERT, I. (2003). Azasterols as inhibitors of sterol 24-methyltransferase in Leishmania and Trypanosoma cruzi. J Med Chem 46, 4714-1727.
19. MARTIN, M.B., GRIMLEY, J.S., LEWIS, J.C., HEATH, H.T., III, BAILEY, B.N., KENDRICK, H., YARDLEY, V., CALDERA, A., LIRA, R., URBINA, J.A., MORENO, S.N.J., DOCAMPO, R., CROFT, S.L. & OLDFIELD, E. (2001). Bisphosphonates inhibit the growth of Trypanosoma brucei, Trypanosoma cruzi, Leishmania donovani, Toxoplasma gondii, and Plasmodium falciparum: A potential route to chemotherapy. J Med Chem 44, 909-916.
20. MARTINEZ-PALOMO, A., DE SOUZA, W. & GONZALES-ROBBLES, A. (1976). Topographical differences in the distribution of surface coat components and intramembrane particles. A cytochemical and freeze-fracture study in culture forms of Trypanosoma cruzi. J Cell Biol 69, 507-513.
21. MCCABE, R.E. (1988). Failure of ketoconazole to cure chronic murine Chagas disease. J Infect Dis 158, 1408-1409.
22. MCCABE, R.E., REMINGTON, J.S. & ARAÚJO, E.G. (1984). Ketoconazole inhibition of intracellular multiplication of Trypanosoma cruzi and protection against a lethal infection with the organism. J Infect Dis 150, 594-601.
23. MCCABE, R.E., REMINGTON, J.S. & ARAÚJO, E.G. (1986). In vitro and in vivo effects of itraconazole against Trypanosoma cruzi. Am J Trop Med Hyg 35, 280-284.
24. MOREIRA, A.A., DE SOUZA, H.B.W.T., AMATO NETO, V., MATSUBARA, L., PINTO, P.L.S., TOLEZANO, J.E., NUNES, E.V. & OKUMURA, M. (1992). Evaluation of the therapeutic activity of itraconazole in chronic infections, experimental and human, by Trypanosoma cruzi. Rev Inst Med Trop S Paulo 34, 177-180.
25. NASIRUDEEN, A.M.A., HIAN, Y.E., SINGH, M. & TAN, K.S.W. (2004). Metronidazole induces programmed cell death in the protozoan parasite Blastocystis hominis. Microbiology 150, 33-43.
26. PARIS, C., LOISEAU, P.M., BORIES, C. & BREARD, J. (2004). Miltefosine induces apoptosis-like death in Leishmania donovani promastigotes. Antimicrob Agents Chemother 48, 852-859.
27. PETRANYI, G., RYDER, N.S. & STUTZ, A. (1984). Allylamine derivatives: New class of synthetic antifungal agents inhibiting fungal squalene epoxidase. Science 224, 1239-1241.
28. PIMENTA, P.F., DE SOUZA, W., SOUTO-PADRON, T. & PINTO DA SILVA, P. (1989). The cell surface of Trypanosoma cruzi: A fracture-flip, replica-staining label-fracture survey. Eur J Cell Biol 50, 263-271.
29. RODRIGUES, C.O., CATISTI, R., UYEMURA, S.A., VERCESI, A.E., LIRA, R., RODRIGUEZ, C., URBINA, J.A. & DOCAMPO, R. (2001). The sterol composition of Trypanosoma cruzi changes after growth in different culture media and results in different sensitivity to digitonin permeabilization. J Eukaryot Microbiol 48, 588-594.
30. 24(25)-sterol methyltransferase inhibitor, on promastigote and amastigote forms of Leishmania amazonensis. Antimicrob Agents Chemother 46, 487-499.
31. RYDER, N.S. (1988). Mechanism of action and biochemical selectivity of allylamine antimycotic agents. Ann NY Acad Sci 544, 208-220.
32. SOARES, M.J. & DE SOUZA, W. (1991). Endocytosis of gold-labeled proteins and LDL by Trypanosoma cruzi. Parasitol Res 77, 461-468.
33. TURRENS, J.F., BOVERIS, A., GROS, E.G. & STOPPANI, A.O.M. (1980). Distribucion subcelular de ergosterol y esteroles 5,7-dienicos en Trypanosoma cruzi. Medicina 40, 137-144.
34. URBINA, J.A. (1997). Lipid biosynthesis pathways as chemotherapeutic targets in kinetoplastid parasites. Parasitol 114(suppl.), S91-S99.
35. URBINA, J.A. (2002). Chemotherapy of Chagas disease. Curr Pharm Des 8, 287-295.
36. URBINA, J.A., LAZARDI, K., AGUIRRE, T., PIRAS, M.M. & PIRAS, R. (1988a). Antiproliferative synergism of the allylamine SF-86327 and ketoconazole on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi. Antimicrob Agents Chemother 32, 1237-1242.
37. URBINA, J.A., LAZARDI, K., AGUIRRE, T., PIRAS, M.M. & PIRAS, R. (1991). Antiproliferative effects and mechanism of action of ICI 195,739, a novel bis-triazole derivative, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi. Antimicrob Agents Chemother 35, 730-735.
38. URBINA, J.A., LAZARDI, K., MARCHAN, E., VISBAL, G., AGUIRRE, T., PIRAS, M.M., PIRAS, R., MALDONADO, R.A., PAYARES, G. & DE SOUZA, W. (1993). Mevinolin (lovastatin) potentiates the antiproliferative effects of ketoconazole and terbinafine against Trypanosoma (Schizotrypanum) cruzi: In vivo and in vitro studies. Antimicrob Agents Chemother 37, 580-591.
39. URBINA, J.A., PAYARES, G., CONTRERAS, L.M., LIENDO, A., SANOJA, C., MOLINA, J., PIRAS, M., PIRAS, R., PEREZ, N., WINCKER, P. & LOEBENBERG, D. (1998). Antiproliferative effects and mechanism of action of SCH 56592 against Trypanosoma (Schizotrypanum) cruzi: In vitro and in vivo studies. Antimicrob Agents Chemother 42, 1771-1777.
40. URBINA, J.A., PAYARES, G., MOLINA, J., SANOJA, C., LIENDO, A., LAZARDI, K., PIRAS, R., PEREZ, N., WINCKER, P. & RYLEY, J.F. (1996a). Cure of short and long-term experimental Chagas disease using D0870. Science 273, 969-971.
41. URBINA, J.A., PAYARES, G., SANOJA, C., CONTRERAS, L.M., LIENDO, A., PIRAS, M.M. & PIRAS, R. (1996b). In vitro and in vivo antiproliferative effects of SCH 56592 against Trypanosoma cruzi, the causative agent of Chagas disease. ICAAC Abstr 36, F102.
42. 24(25)-sterol methyltransferase block sterol synthesis and cell proliferation in Pneumocystis carinii. Antimicrob Agents Chemother 41, 1428-1432.
43. URBINA, J.A., VIVAS, J., RAMOS, H., LARRALDE, G., AGUILAR, Z. & AVILAN, L. (1988b). Alteration of lipid order profile and permeability of plasma membranes from Trypanosoma cruzi epimastigotes grown in the presence of ketoconazole. Mol Biochem Parasitol 30, 185-196.
44. 24(25)-sterol methyl transferase inhibitors and their combinations with ketoconazole. Mol Biochem Parasitol 73, 199-210.
45. VANNIER-SANTOS, M.A., PIMENTA, P.F. & DE SOUZA, W. (1988). Effects of phorbol ester on Leishmania mexicana amazonensis: An ultrastructural and cytochemical study. J Submicrosc Cytol Pathol 20, 583-593.
46. VANNIER-SANTOS, M.A., URBINA, J.A., MARTINY, A., NEVES, A. & DE SOUZA, W. (1995). Alterations induced by the antifungal compounds ketoconazole and terbinafine in Leishmania. J Eukaryot Microbiol 42, 337-346.
47. VERMA, N.K. & DEY, C.S. (2004). Possible mechanism of miltefosine-mediated death of Leishmania donovani. Antimicrob Agents Chemother 48, 3010-3015.
48. 24(25)-sterol methyltransferase inhibitors and their combinations with ketoconazole. Int J Antimicrob Agents 7, 235-240.
49. WORLD HEALTH ORGANIZATION. (2002). Strategic direction for Chagas disease research. TDR Report. Geneva: Author.